Acadia Healthcare (NASDAQ:ACHC) Releases FY 2026 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.300-1.550 for the period, compared to the consensus earnings per share estimate of 1.750. The company issued revenue guidance of $3.4 billion-$3.5 billion, compared to the consensus revenue estimate of $3.4 billion.

Acadia Healthcare Price Performance

ACHC opened at $17.17 on Wednesday. The firm has a market cap of $1.58 billion, a PE ratio of 14.68, a P/E/G ratio of 4.94 and a beta of 0.89. The stock has a 50-day moving average price of $14.35 and a 200-day moving average price of $18.50. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $42.85. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS. Sell-side analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ACHC shares. Barclays lowered their price objective on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Thursday, December 4th. Bank of America cut Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $21.50 to $13.00 in a research report on Wednesday, December 3rd. Leerink Partners downgraded Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Finally, TD Cowen reiterated a “reduce” rating on shares of Acadia Healthcare in a research note on Friday, January 16th. Six investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $18.23.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Wells Fargo & Company MN increased its holdings in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after buying an additional 1,510 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Aristides Capital LLC purchased a new position in Acadia Healthcare during the fourth quarter valued at $196,000. Prudential Financial Inc. grew its holdings in Acadia Healthcare by 21.9% during the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after purchasing an additional 1,780 shares during the period. Finally, Glenmede Investment Management LP increased its position in Acadia Healthcare by 15.6% in the third quarter. Glenmede Investment Management LP now owns 11,379 shares of the company’s stock worth $282,000 after buying an additional 1,532 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.